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10ABSTRACT
The aryl hydrocarbon receptor (AhR) plays an important role in
several biological processes such as reproduction, immunity and
homoeostasis. However, little is known on the chemical-structural
and physicochemical features that influence the activity of AhR
15antagonistic modulators. In the present report, in vitro AhR antag-
onistic activity evaluations, based on a chemical-activated luciferase
gene expression (AhR-CALUX) bioassay, and an extensive literature
review were performed with the aim of constructing a structurally
diverse database of contaminants and potentially toxic chemicals.
20Subsequently, QSAR models based on Linear Discriminant Analysis
and Logistic Regression, as well as two toxicophoric hypotheses
were proposed to model the AhR antagonistic activity of the built
dataset. The QSAR models were rigorously validated yielding satis-
factory performance for all classification parameters. Likewise, the
25toxicophoric hypotheses were validated using a diverse set of 350
decoys, demonstrating adequate robustness and predictive power.
Chemical interpretations of both the QSAR and toxicophoric mod-
els suggested that hydrophobic constraints, the presence of aro-
matic rings and electron-acceptor moieties are critical for the AhR
30antagonism. Therefore, it is hoped that the deductions obtained in
the present study will contribute to elucidate further on the struc-
tural and physicochemical factors influencing the AhR antagonistic
activity of chemical compounds.
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35The aryl hydrocarbon receptor (AhR) is an evolutionary conserved transcription factor
member of the basic helix–loop–helix (bHLH) family of receptors [1]. The AhR acts as
a cytoplasmatic chemical sensor mediating intracellular and cellular signals [2] with its
main transcriptional regulatory function being the up-regulation of cytochrome P450
family 1 (CYP1) of metabolizing enzymes [3]. The AhR Ligand Binding Domain (LBD) has
40been suggested to be one of its two PER-ARNT-SIM (PAS) domains, the PAS-B [4].
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However, comprehensive understanding of the structural and functional profile of the
AhR has been limited by the unavailability of an experimentally determined AhR structure
co-crystallized with the corresponding functional domains. Consequently, studies aimed
at elucidating the interaction modes involved in the AhR signal transduction pathway
45have relied on homologous systems [5].
AhR owes its first discovery to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which is one
of the most toxic synthetic compounds known to date and whose effects in biological
systems are attributed to the AhR binding and activation [3]. Along with TCDD, several
dioxin and dioxin-like compounds have been studied for their AhR agonistic activity and
50associated toxicological effects [6,7]. However, the ability of AhR to interact with
a structurally diverse spectrum of xenobiotic and endogenous ligands suggests that it is
highly promiscuous [8].
The induction of the AhR/CYP1A1 axis, as a consequence of AhR agonism, has been
reported to enhance oestrogenic detoxification [9], regulate the oxidative balance and to
55propagate the metabolism of proinflammatory and tumour-promoting metabolites,
among other effects [10]. Moreover, AhR plays an important role in the physiological
functions of reproductive organs, immune system, liver and vascular development, car-
diac function, cell growth, differentiation, homoeostasis and circadian rhythms [2,11–13].
On the other hand, several toxicants and high concern substances have been reported as
60antagonists of AhR transcriptional activity [7,14]. However, in contrast to AhR agonism,
little attention has been paid to the analysis of the biochemical consequences of AhR
antagonism and even less on the subsequent toxicological implications [15–17].
Computational models, coupled with in vitro assays, have in the recent times gained
increasing utility as alternative tools for providing insight on the pharmacological and/or
65toxicological effects of chemical compounds [18]. Indeed when proper interpretations are
feasible, these techniques jointly provide solid understanding on the structural and
functional characteristics relevant for studied bioactivity profiles [19], in addition to
their inherent ethical, economic and predictive advantages [20].
It should be noted that most of the AhR computational models reported in the
70literature have been based on the binding affinity as the endpoint, which is an important
drawback since it does not discriminate between agonists and antagonists [21,22]. In
addition, as an experimentally determined AhR structure including the respective func-
tional domains is unavailable, in silico initiatives have relied on homology models of the
PAS-B domain to provide insights on the possible ligand binding modes [5]. The differ-
75ences observed in these studies between the agonistic and antagonistic interaction
modes suggested greater distortions in the structure of the LBD in case of the latter
[5,23]. Nonetheless, little is still known on the chemical structural and functional features
that favour the binding of AhR antagonists [24].
Therefore, further analyses of the agonist and/or antagonist responses following AhR
80binding are needed to gain better understanding of role of the AhR in both toxicological
and pharmacological contexts [25]. Certainly, informative experimental bioassays will be
necessary to obtain greater insight on the AhR-ligand interaction modes, and particularly
to discriminate between agonistic and antagonistic modulations. One of the most popu-
larized assays is the in vitro AhR Chemically Activated LUciferase eXpression (CALUX)
85bioassay, which has been reported to be useful in the detection of the AhR antagonistic
and agonistic effects of dioxin and dioxin-like chemical compounds [26,27]. This assay is
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based on the analysis of the induced luciferase response in a recombinant cell line driven
by several CYP1A1 dioxin response elements (DREs) as a direct reflection of AhR-mediated
transcriptional activity.
90The goal of the present manuscript is to analyse the factors, from a chemical perspec-
tive, that influence the AhR antagonism of chemical compounds using a combination of
in vitro and in silico methods. Firstly, a CALUX reporter gene assay for the AhR antag-
onistic activity for a set of selected xenobiotics with known toxicity profiles was per-
formed. Then, based on the results obtained from the in vitro assays and an extensive
95literature review, QSAR and toxicophoric models were built to examine the chemical
structural and physicochemical features that modulate AhR antagonism. It should be
noted that while QSAR methods have been employed to model and predict the AhR
binding capacity [28,29], this is the first time that in vitro, QSAR and toxicophoric




A set of 68 chemical compounds was tested in vitro for their AhR antagonistic activity due
to their suspected or suggested toxic effects. Twenty-nine of them correspond to
105Persistent Organic Pollutants (POPs) prevalent in Scandinavian human blood [30] and
the remaining 39 corresponded to a chemical library belonging to the Laboratory of Food
Analysis of the University of Liège. The tested compounds were mostly obtained from
Sigma-Aldrich (Missouri, USA), for details see Supporting Information SI-1. All the chemi-
cals were dissolved in dimethyl sulphoxide (DMSO) (Acros Organics, Molinons, France) as
110the stock solution of 20 mg/mL and kept in −20°C. The standard solution of 2,3,7,8-tetra-
chlorodibenzodioxin (TCDD) (purity > 98%) in DMSO was supplied from Wellington
laboratories (Guelph, Canada). The reagent 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) was obtained from Sigma Aldrich (Missouri, USA).
AhR CALUX assay
115The AhR-CALUX bioassay was developed based on a stably transfected dioxin response
(DR) rat hepatoma (H4IIE) cell line, consistent with previous reports in the literature [6,31].
These cells were obtained from BioDetection System (BDS) (Amsterdam, The Netherlands)
transfected with four native dioxin response elements from the upstream region of the
mouse cyp1a1 gene leading the Mouse Mammary Tumour Virus (MMTV) promoter and
120controlling expression of the luciferase gene were stably integrated into the cell’s gen-
ome. The AhR transactivation activity of the compounds was reported as the expression of
the inserted luciferase and measured by light production.
The cells were maintained in α-MEM (ThermoFisher, Massachusetts, USA) with 10% v/v
foetal bovine serum (Greiner, Kremsmünster, Austria) and 50 IU/mL penicillin and 50 μg/mL
125streptomycin (Sigma Aldrich, USA) and were incubated at 37°C in a water saturated atmo-
sphere injected with 5% CO2.
The AhR antagonistic tests for dioxin responsive chemical-activated luciferase gene
expression (AhR-CALUX) bioassays were performed as indicated by the provider BDS.
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Briefly, after reaching about 90% of confluence in the culture flask, the cells were
130trypsinized and seeded homogenously in white clear-bottomed 96 well microplates
(Greiner, Kremsmünster, Austria). The cells were then incubated for 24 h and afterwards
treated with the test compounds for another 24 h. The experiment was terminated by cell
lysis using lysis solution containing Triton X100 (Sigma Aldrich, Missouri, USA). After
adding luciferin (Promega, Wisconsin, United States) and ATP (Roche Diagnostics,
135Rotkreuz, Switzerland) to the cell lysate, the plates were read by a luminometer (ORION
II, Berthold Detection System, Pforzheim, Germany).
For antagonistic tests, the cells were co-exposed to the test compounds and 15 pM
TCDD corresponding to TCDD EC50 in DR-H4IIE. All the experiments were repeated at least
three times independently. The maximum concentration tested to determine the AhR
140antagonistic activity was 40 μM with some exceptions (see SI-1), and the final concentra-
tion of DMSO in the culture mediumwas 0.4%. To ensure the adequacy of the test method
and provide a basis for comparisons, a reference curve of the positive control TCDD, as
well as concurrent negative and solvent controls were added on each plate.
Cell viability assay
145An analysis of the MTT cell viability as well as a visual inspection of the cell morphology
and attachment were performed to detect the cytotoxic compounds. After exposure to
the test compounds, 25 μL of MTT solution 5 mg/mL was added into each well. The plates
were then incubated for 4 h at 37°C to allow for the formation of the purple metabolite
formazan from the tetrazolium dye MTT via the activity of the mitochondrial succinate
150dehydrogenase. Later, the formazan crystals were dissolved during 2 h by adding 100 μL
of isopropanol. The MTT formazan absorbance was read at 550/630 nm using a microplate
spectrophotometer (ELX800TM BioTek Inc., Winooski, USA).
Results for both reporter gene and MTT assays were presented as relative responses,
either as the percentage of the cell response to the tested compound compared to the
155cell response to TCDD EC50 on the same plate for CALUX assays, or to solvent control
DMSO for MTT test. A compound was considered an AhR antagonist when it was able to
reduce the activity of the TCDD EC50 from 100% to at least 70%, while reductions in cell
population greater than 15% were considered cytotoxic [32].
QSAR models
160Based on both the experimental in vitro results obtained herein and those compiled from
an extensive review of the literature, binary classifiers of AhR antagonism were built using
statistical modelling methods. Themolecular characterization was conducted by means of
simple and interpretable chemical structural descriptors.
Structures, descriptors and activity
165A dataset of 116 chemicals was built to develop the QSAR classification models. This set
comprised of 68 compounds tested in the present report for their AhR antagonistic
activity and 48 compounds retrieved from literature. From this dataset, compounds
with undetermined or inconsistent activity were excluded from the analysis and therefore
minimizing potential error sources (for details see SI-1). A binary scale of activity values
170was considered in the sense that the compounds observed or reported in the literature to
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induce the AhR antagonistic effect, based on the AhR-CALUX method, were labelled as
active while those that did not induce any effect were considered as inactive.
The calculated molecular descriptors were implemented in-house, based on definitions
obtained from DRAGON [33] and PADEL [34] software. Consistent with the parsimony
175principle, only the simplest characterizations of the molecular structures were considered.
A total of 1929 DRAGON descriptors were calculated corresponding to: constitutional
descriptors, information indices, functional group counts, atom-centred fragments, 2D
binary fingerprints and 2D frequency fingerprints. From this set, constant variables or
those with pair-correlations greater than 0.9 were removed, retaining only 171 descrip-
180tors. As for the PADEL software, the Estate and MACCS fingerprints were computed
yielding 245 descriptors from which 15 constants were removed. Globally, a total of 401
molecular descriptors were retained and subsequently used as input variables for the
chemoinformatic modelling.
Variables and QSAR methods
185The selection of molecular descriptors for modelling the AhR antagonistic activity was
carried out using the information gain filter as provided by IMMAN software [35]. The
information gain defined as the reduction in variable entropy (or uncertainty) given that
another variable (response variable in this context) is known. This measure allows vari-
ables to be ranked based on their capacity to discriminate cases that belong to different
190classes and consequently filter out informative variables.
A Principal Components Analysis (PCA) was performed on the selected set of variables
and 10 principal components (PCs), explaining more than 90% of the total variance, were
obtained. Subsequently these PCs were used as input variables for modelling the AhR
antagonistic activity. The PCs were rotated using the orthogonal rotation scheme varimax
195to maximize the sum of variances of the squared loadings. For the PCA the MATLAB
software [36] was employed.
Linear Discriminant Analysis (LDA) and Logistic Regression (LReg) methods were
employed for the classification model building. The metrics considered to evaluate the
performance of the built classification models were the accuracy, precision, sensitivity and
200specificity (see below) where: TA = true active; FA = false active; TI = true inactive and
FI = false inactive.
Accuracy ¼ TAþ TIð Þ
TAþ FIþ FAþ TIð Þ  100%
Precision ¼ TA
TAþ FAð Þ  100%
Sensitivity ¼ TA
TAþ FIð Þ  100%
Specificity ¼ TI
TIþ FAð Þ  100%
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Validation methods & applicability domain
Internal and external validation experiments were designed to assess the robustness and
predictiveness of the built classification models. To this end, a cluster analysis was
205performed to rationally divide the dataset in training and test sets, based the following
procedure: first, with hierarchical clustering (based on the square-Euclidean distance as
the similarity criterion) an optimal number of clusters (k) was established using the graph
of the amalgamation schedule. Then, k-Means method was employed to stratify the
structures into clusters according to their similarity. An appropriate distribution of active
210and inactive compounds was considered during the clustering. With this procedure, two
subsets of compounds were generated with 75% of the data comprising the training set
and 25% test set. Internal leave-group-out cross validation (25% of the training set was
held out for validation for each fold) was performed to check for possible overfitting
during the model building procedure. Ten different combinations of training and test sets
215were created using cluster analysis and a 10-fold external validation was performed to
evaluate the average predictive capacity of the models. This approach has been recom-
mended as the most stringent validation protocol for QSAR models [19]. For the cluster
analysis, the STATISTICA [37] software was employed.
The applicability domain (AD) of the built QSAR models was established by using the
220Euclidean distances and Tanimoto coefficients as the structural similarity measures and
the k-nearest neighbour algorithm (k-NN) as the feature space approximator. For this AD
analysis the AmbitDiscovery software [38] was used.
Toxicophoric modelling
A diverse set of active AhR antagonistic compounds was selected from the dataset built in
225the present report for mapping the toxicophoric hypothesis. The selection criterion was
based on the hierarchical and k-means clustering previously described. Additionally,
a Tanimoto matrix score provided by the PubChem [39] platform was considered. For
this study, the PHASE module of Schrödinger [40] software was used.
The three-dimensional structures of the selected set of active AhR antagonistic compounds
230were generated and employed to build toxicophoric models following a ligand-dependent
approach exclusively. The mapped space was unrestricted by considering all volumes and
shapes, but with locations and orientations in 3D-spaces allowing the enantiomeric discrimi-
nation by absolute coordinated distances. All the available features included in PHASE were
analysed at distances of 1.8Å and with a tolerance of 2.0 Å to match the hypothesis. These
235features were represented in the toxicophoric models as (A) acceptor, (D) donor, (H) hydro-
phobic, (N) negative ionic, (P) positive ionic, and (R) aromatic ring. The best alignment was
searched considering 50 conformations for each compound. The generated hypotheses were
accepted if they fitted at least 50% of the training set. Three to seven features were considered
as optimum for hypothesis acceptability.
240The goodness of fit of the toxicophoric hypotheses was evaluated using the
Boltzmann-enhanced discrimination of receiver operating characteristic (BEDROC),
which is a generalization of the ROC metric to deal with the early recognition problem.
The difference criterion between toxicophoric models was set to 0.5, while the Phase
Hypo Score was employed as the scoring function. The mathematical definitions for all
6 E. GOYA-JORGE ET AL.
245these metrics are detailed elsewhere and the performance is measured from 0–1 values
where 1 represents perfect fitness [41].
Finally, an external set of decoy structures was generated using as seeds the diverse set
of active AhR antagonistic compounds employed in the toxicophore hypothesis building.
For decoy structure generation, the Directory of Useful Decoys (DUD•E) online platform
250was employed. DUD•E constitutes the largest and most comprehensive public dataset for
benchmarking virtual screening programsQ3 and was employed here to validate the pre-
dictive capacity of the toxicophoric hypotheses. DUD•E is designed to provide sets of
structures with similar physicochemical properties but dissimilar topology to the active
compounds being, therefore, unlikely binders [42].
255Results and discussion
In vitro results
Out of the 68 test compounds evaluated with the AhR-CALUX assay, 24 of these induced
AhR antagonistic transactivity, suppressing the cell response to the spike-in control 15 pM
TCDD from 100% to at least 70%. Three of these, two insecticide isomers (α-endosulfan
260and β-endosulfan) and the fungicide thirame, reduced the cell viability by more than 15%.
Moreover, the former two showed cytotoxic effects in more than 60% of the cell popula-
tion at a concentration of 40 μM while the latter showed a similar effect even at 20 μM.
These three chemicals were therefore excluded from the analysis of AhR antagonism (see
SI-1). The remaining 41 chemicals did not show any AhR antagonistic potential and were
265thus considered as inactive.
QSAR modelling
Database of structures and ahr antagonism
A dataset of 116 chemical compounds with defined AhR antagonistic activity profiles
based on the DR-H4IIE cell line was constructed. This database contained organo-
270halogenated (chlorinated, brominated, fluorinated), polyaromatic hydrocarbon, flavonoid,
quinone, imidazole, bisphenol and pyrethroid chemical classes. Although a few antibiotics
and phytochemicals were included, most of the modelled structures are or have been
used as industrial chemicals, pesticides, fungicides, algaecides, insecticides, rodenticides
and herbicides. Many of these profiled compounds are reported as potential endocrine
275disruptors or have been already banned due to their toxic spectrum through different
mechanisms.
During the construction of the dataset, interest was placed on the homogeneity of the
results obtained from the experimental protocols, in order to obtain logical and inter-
pretable conclusions. Therefore, compounds with ambiguous and/or unclear experimen-
280tal determinations were discarded, especially for those results extracted from literature.
Such stringent selectiveness has been strongly supported by several reports in the
literature [19].
The hexachlorocyclohexane (HCH) conformational isomers (α-, β-, γ-, δ-HCH) were
excluded since they possessed contrasting activity profiles (the descriptors used in the
285present study are insensitive to stereochemical differences). For the same reason, two
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polycyclic aromatic hydrocarbons were excluded. The hexabromocyclododecane (HBCD)
in vitro activity was the only one considered, while the rest of the isomers (α-, β-, γ-HBCD)
reported in the literature were discarded. Finally, one structural outlier (chlormequat
chloride) was removed during the modelling due to disconnected fragments in the
290molecular structure.
Moreover, BDE-49 (i.e. 2,2ʹ,4,5ʹ-tetrabromodiphenyl ether) [43] and nine polychlori-
nated biphenyls (PCBs) [7] were excluded as their activity profiles were not clearly defined
in the literature (see SI-1). Three cytotoxic compounds in the MTT assay were not
considered (see above).
295A standard protocol was followed to guarantee the homogeneity of the final dataset
presented in this study that included 93 compounds, 40 active AhR antagonists and 53
inactive. Therefore, this dataset may be considered of acceptable quality and is, to the
best of our knowledge, the largest for AhR antagonistic activity reported so far.
Selection and transformation of molecular descriptors
300The calculated molecular descriptors were all based on simple and interpretable features
of the chemical compounds. Due to the large number of generated descriptors, dimen-
sionality reduction was deemed necessary.
From the calculated 401 molecular descriptors, a set of 96 descriptors was retrieved
using the aforementioned information gain filter, and subsequently used to generate
305orthogonal descriptors using the PCA method. Ten PCs were determined to be the
optimum number of PCs based on the eigenvalues of the generated covariance matrix
and these described 90% of the total variance in the dataset. The matrix of the PCs
coefficients obtained for the set of molecular descriptors and the scores for all the PCs are
provided as supplementary information (SI-2).
310QSAR models obtained
For the QSAR modelling of the AhR antagonistic activity, simple and interpretable
classification algorithms were preferred. Hence, five models were selected following
commonly established criteria [19], three corresponding to LDA and two corresponding
to LReg methods. The training metrics obtained for these models are shown in Table 1
315and additional parameters are provided as SI-3. One of the significant advantages offered
by these statistical models, compared to most machine learning algorithms such as
random forest, support vector machine or artificial neural networks, is the straightforward
Table 1. Evaluation metrics of the QSAR models.
Modela PCs
Accuracy Precision Sensitivity Specificity
Trainb Ext.Vc Trainb Ext.Vc Trainb Ext.Vc Trainb Ext.Vc
LDA 10 88.51 81.48 87.02 73.49 88.01 83.56 89.21 79.95
LDA 9 83.02 81.94 87.02 73.58 88.12 83.33 78.11 79.62
LDA 6 78.01 74.07 76.04 65.33 63.23 77.58 89.30 68.95
LReg 7 88.50 73.61 88.51 64.89 88.20 74.78 89.22 72.14
LReg 6 93.51 78.24 87.01 70.32 88.14 74.89 99.03 79.00
a QSAR models based on linear discriminant analysis (LDA) and logistic regression (LReg).
b Value of the classification metrics obtained during the training of the models (Additional parameters in SI-3).
c Average of the classification metrics made during the 10-fold external validation procedure.
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interpretation and consequently applicability in the rationalization of the influence of the
different chemical structural features on the modelled property [44].
320Moreover, both the internal and external validation procedures yielded adequate
statistical parameters, demonstrating the robustness and predictive capacity of the five
QSAR models obtained herein. Indeed, all the selected models showed good external
validation performance, yielding percentages higher than 60% for accuracy, precision,
sensitivity and specificity (Table 1).
325These models are the first QSARs for AhR antagonistic activity of which we are aware.
Previous QSAR models reported in the literature focused on AhR agonism or non-specific
AhR-ligand binding [28,45]. Moreover, the models presented herein were built over
a diverse dataset of chemicals and were observed to be consistent with the OECD
validation principles [46]. Therefore, these models can reliably predict the AhR antago-
330nistic potential of untested chemicals in their AD.
Toxicophoric mapping
Toxicophoric (or Pharmacophoric) models are defined as an ensemble of steric and
electronic features that are necessary to ensure the optimal supramolecular interactions
with a specific biological target and to trigger (or block) its biological response [47].
335Toxicophoric modelling aims to identify a set of features or restrictions in the molecules
and/or their receptors that determine their capacity to interact in any mode and conse-
quently cause toxic effects. These models may be built following structure-based or
ligand-based approaches depending on whether the information of the target receptor
is employed or not [48,49].
340Herein, as a fully crystalized structure of the AhR protein (containing the PAS-B ligand
binding domain) is not yet available [25], a ligand-based toxicophoric modelling was
performed. The cluster analysis performed during the QSAR modelling was employed to
select the most dissimilar compounds for the toxicophoric mapping.
Seven most dissimilar structures were selected (Figure 1) and used to explore toxico-
345phoric hypothesis of AhR antagonism. These chemical compounds are considered to be
an environmental and health threat and they showed strong antagonistic activity in the
in vitro AhR-CALUX assay.
A total of 8 toxicophoric hypotheses were obtained and their performance assessed
based on the internal validation enrichment metrics. Consequently, two toxicophoric
350models were selected as they showed adequate performance and contributed dissimilar
structural information.
Figure 2(a,b) show the spatial representations of the selected Toxicophoric-AhR antag-
onistic hypotheses for the first: Hydrophobic_Hydrophobic_Hydrophobic_ Aromatic Ring
(HHHR) and the second: Acceptor_Hydrophobic_Hydrophobic_ Aromatic Ring (AHHR)
355models, respectively. Both arrangements included a common segment of two hydropho-
bic constraints and an aromatic ring as critical features. On the other hand, the latter
model included an electro-acceptor group while the former possessed an additional
hydrophobic constraint.
An external validation of the two selected AhR-antagonistic toxicophoric models was
360conducted as recommended [42], using a diverse dataset of 350 decoy structures gener-
ated from the seven active molecules employed in the hypotheses exploration.
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The training and the corresponding external validation results of the HHHR and AHHR
toxicophoric hypotheses are shown in Table 2. Overall, the built hypotheses showed good
performance as all validation metrics were greater than 0.5 and thus demonstrating their
365robustness and predictive capacity.
Several pharmacophoric models considering nuclear receptors ERα and ERβ as drug
targets [50,51] have been reported in the literature. However, limited distinctions
between agonist and antagonistic ligands have been suggested [52]. Furthermore, the
few toxicophoric considerations available are generally restricted to drug-safety contexts
Figure 1. Active structures selected for toxicophoric modelling (For details see SI-1).
Figure 2. Representation of the toxicophoric models designed in Schrödinger software.
Hydrophobic (green-ball), ring (orange ring), acceptor group (pink ball with signalling arrows).
a. HHHR: Hydrophobic_Hydrophobic_Hydrophobic_Aromatic Ring. b. AHHR: Acceptor_Hydro
phobic_Hydrophobic_Aromatic Ring.
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370[48,49]. Nevertheless, some successful and experimentally validated studies on enzymatic-
mediated endocrine disruptive mechanisms have been reported based on the inhibition
of 17β-hydroxysteroid dehydrogenases [53].
The first pharmacophoric/toxicophoric estimations based on the blocking capacity of
chemicals over AhR are herein proposed. Moreover, considering the good predictive
375power offered by these computational models, they could be a useful virtual screening
tool for chemical compounds with potential AhR antagonistic activity.
Structural and physicochemical interpretations
As an essential receptor whose cellular implications are still being discovered, the disrup-
tion of the AhR functions could lead to toxic effects that are yet to be fully understood
380[3,8,11,12]. Hence, the mapping of chemical structural features critical for the AhR ago-
nistic/antagonistic potential could enhance the identification of specific modulators with
possible toxic profiles. In this sense, based on the developed QSAR and toxicophore-
based models, analyses were performed to further understand how different chemical-
structural features influence the AhR antagonistic activity.
385The interpretation of computational models is highly recommended by the OECD
guidelines to enhance the utility of the QSAR predictive results [46]. Here, only simple
0-2D descriptors were calculated and used for the model building, therefore the elucida-
tion of their contribution to the AhR antagonistic activity in chemical structural terms is
straightforward. On the other hand, the toxicophore-based methods provide information
390on the steric and electrostatic features deemed critical for a given toxicity (or activity)
profile. Hence both QSAR and toxicophore models may serve as complementary
approaches providing a more complete outlook of the structural and physicochemical
factors that influence the AhR antagonistic activity.
The molecular descriptors with relevant contribution were determined based on the
395PCA factor loadings (SI-2). It has been previously reported that coefficients greater than
0.7 are considered remarkably influential to the generated PCA components [54].
Therefore, the same cut-off was considered to identify the most influential descriptors
on the modelled AhR antagonism. Definitions and SMARTS [55] representations of the top
five variables obtained are provided in Table 3.
400From the toxicophoric models, hydrophobic interactions were identified as an impor-
tant constraint in active AhR antagonistic molecules. Moreover, the presence of an
aromatic ring and an electron acceptor group was suggested as relevant for AhR
Table 2. Results of the training and the external validation for HHHR and AHHR
toxicophoric hypotheses.
Hypothesis
Training performance External validation
PHASEc BEDROCd PHASEc BEDROCd
HHHRa 0.93 0.68 0.93 0.98
AHHRb 0.82 0.69 0.82 0.92
a HHHR: Hydrophobic hydrophobic hydrophobic aromatic ring.
b AHHR: Acceptor hydrophobic hydrophobic aromatic ring.
c Scoring function phase hypo score [41].
d Boltzmann-enhanced discrimination of receiver operating characteristic (BEDROC) [41].
SAR AND QSAR IN ENVIRONMENTAL RESEARCH 11
antagonism. These features will now be analysed in detail and the possible complemen-
tarity with the QSAR model variables also explored.
405Hydrophobic constraints
The hydrophobic features comprising the toxicophoric model and the QSAR model
descriptors codifying information on hydrophobicity (i.e. hydrocarbon chains without
attached heteroatoms (H-046) and closed hydrophobic circuits (nCIR) of saturated cyclic





H attached to C (sp3) no X attached to next C
nCconj
Sum of the number of non-aromatic conjugated C(sp2) belonging to any conjugated system, excluding
aromatic rings. Including the following atom types: = C<, = N-, = P-, = B-, = N<, = P<, = S<, >P(=)-, >B
(=)-, = O, = S
H-052
H attached to C(sp3) with 1X attached to next C
nBM Multiple bonds
nCIR Number of circuits
* Brief definitions/representations of the descriptors using the SMARTs [55] formats of the codified features are provided.
The range of values obtained was: H-046 [0–10]; nCconj [0–6]; H-052 [0–12]; nBM [0–26]; nCIR [0–28].
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hydrocarbons) suggest that non-polar structural segments probably play an important
410role in AhR-ligand interactions. Indeed, early studies on TCDD where AhR was simply
considered as an intracellular, soluble and unknown receptor protein, already recognized
its hydrophobic character [56].
Some other reports in the literature have also highlighted the importance of hydrophobi-
city in AhR-LBD interactions e.g. a strong correlation has been found between the suppression
415of AhR on TCDD-induced activity and the hydrophobicity of curcumin derivatives [17]. It has
also been suggested that the affinity of stilbene derivatives of resveratrol to AhR is enhanced
by substituents with high hydrophobicity, among other factors [57]. Moreover, an analysis of
the AhR ligand binding pocket revealed that it is comprised predominantly of hydrophobic
residues with some polar segments located near the medial positions of the ligands [58].
420Therefore, structural fragments with strong hydrophobic character should probably be prior-
itized in the design of ligands with possible AhR antagonistic activity.
Ring feature
Similarly, both the toxicophoric hypotheses and the QSAR models included ring features
[circuit number (nCIR), in the case of the latter] as critical for AhR antagonism. Bearing in
425mind that the name AhR is attributed to the polycyclic aromatic hydrocarbons (PAHs),
which were in fact the very first ligands found to interact with this receptor, it is
unsurprising that ring features are suggested to play a critical role in AhR-mediated
interactions probably through non-covalent interactions (i.e. between electron-rich and
electron-deficient aromatic moieties) [59]. These interactions, also named aromatic
430donor–acceptor interactions, have been analysed for several decades in the AhR context
[60,61]. Firstly, early studies hypothesized that π-π-interactions with phenyl and tyrosyl
groups of the AhR protein occurred in the TCDD-mode of action [56]. Also, these inter-
actions have been evoked to rationalize the effect of PBDEs and PCBs upon contact with
dissolved organic matter in the environment [28], and have been suggested to play an
435important role in endocrine disruptive mechanisms e.g. in ER disruption [62].
Nonetheless, it is important to highlight that there ligands without the neutral, hydro-
phobic and non-polar molecular characteristics of PAHs that have also been shown to
have effects on AhR, demonstrating that these interactions depend on the contribution of
multiple factors [2,63].
440Acceptor-group presence
The charge transfer between molecules and biological systems commonly influences the
potential toxicity of the former [64]. Herein, one of the proposed toxicophoric hypothesis
suggested the presence of an acceptor group as a relevant structural feature for AhR
antagonistic activity. Likewise, the QSARmodels comprise various key molecular descriptors
445that could be related to this toxicophoric feature. For example, heteroatoms attached to sp3
carbons (H-046 and H-052), non-aromatic conjugated systems (nCconj) or multiple bonds
(nBM) in general could all contribute to electron deficient fragments in the ligand’s structure
whose interactions may potentially influence the AhR antagonistic effects.
Altogether, the results obtained herein suggest that the presence of electron acceptor
450groups, connected ring systems (preferably aromatic or delocalized moieties), and most
importantly hydrophobic groups seems to be critical for the potential AhR antagonistic
effects.
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Conclusions
Structural and physicochemical determinants of the AhR antagonistic capacity were
455assessed using a combination of in vitro (AhR-CALUX bioassay) and in silico (QSAR and
toxicophoric mapping) methods. In the former, several chemical compounds were eval-
uated, and their antagonistic activity profiles determined. In the latter, QSAR algorithms
based on LDA and LReg were obtained and validated. These models were shown to
possess adequate robustness and predictive power, based on the quality of the obtained
460statistical validation parameters. Moreover, toxicophoric models were derived and the
structural features potentially favouring the AhR antagonistic potential analysed.
Interpretations of the QSAR and toxicophore models revealed that electron acceptor
groups, aromatic or delocalized ring systems, as well hydrophobic moieties probably
favour the AhR antagonistic activity, demonstrating the complementarity of the two
465approaches notwithstanding their dissimilar conceptual basis. The models proposed
herein could be useful in the prediction of the AhR antagonistic capacity of chemical
compounds with toxicological and pharmacological applications.
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